SOLARA: Solara Active Pharma Sciences Limited has submitted the Exchange a copy of the Scrutinizer's Report of Postal Ballot. Further, the Company has informed the Exchange regarding voting results.
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Solara Active Pharma Sciences has informed the exchanges that shareholders have approved the appointment of Mr. Mohanraj Sanjeevi (DIN: 08420411) as a Whole-time Director (Executive Director) through a postal ballot conducted via remote e-voting from February 5 to March 6, 2026. Out of 71,749 shareholders on record, 58.64% of total shares (2,60,39,854 votes) were polled, with an overwhelming 99.97% voting in favour and just 7,752 votes (0.03%) against the resolution. Both promoter group and public institutional investors voted 100% in favour, while public non-institutions showed 99.77% support. His term runs for 3 years from January 1, 2026 to December 31, 2028, with a fixed pay of Rs. 85 lakh per annum plus a variable pay of Rs. 15 lakh per annum.
This is a routine governance announcement confirming a board-level appointment with near-unanimous shareholder backing. Investors are unlikely to see any material impact on the stock price, though it provides clarity on leadership continuity and ongoing management remuneration costs.